ArticleThe Journal of clinical investigation2020

Notch inhibition overcomes resistance to tyrosine kinase inhibitors in EGFR-driven lung adenocarcinoma.

Emilie Bousquet Mur et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.